Dow Down 0.13% Nasdaq Up 0.14%

Endocyte, Inc. (ECYT)

-NasdaqGS
3.18 0.00(0.00%) Jul 29, 4:00PM EDT
|After Hours : 3.18 Down 0.00 (0.02%) Jul 29, 4:46PM EDT
Prev Close:3.18
Open:3.18
Bid:3.10 x 1000
Ask:3.31 x 10000
1y Target Est:8.25
Beta:1.56561
Earnings Date:Aug 2 - Aug 8 (Est.)
Day's Range:3.10 - 3.21
52wk Range:2.65 - 5.87
Volume:185,630
Avg Vol (3m):141,829
Market Cap:134.05M
P/E (ttm):N/A
EPS (ttm):-0.97
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ECYT 0.00%134.05M
SNSSUp 28.44%56.50M
NKTRUp 7.39%2.36B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1,914.95
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.10
Quarterly EPS Est (Jun-16) :-0.26
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases in the United States. The company uses its technology to create novel small molecule drug conjugates (SMDCs) and compani... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback